BIOMAT Database Logo BIOMAT Database Logo

Platelet activity in acute and chronic ischemic heart disease, with reference to the type of hyperlipoproteinemia. 1978

N Stăncioiu, and M L Scrobohaci, and I Zătreanu, and I Orha

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005227 Fatty Acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (FATTY ACIDS, UNSATURATED). (Grant & Hackh's Chemical Dictionary, 5th ed) Aliphatic Acid,Esterified Fatty Acid,Fatty Acid,Fatty Acids, Esterified,Fatty Acids, Saturated,Saturated Fatty Acid,Aliphatic Acids,Acid, Aliphatic,Acid, Esterified Fatty,Acid, Saturated Fatty,Esterified Fatty Acids,Fatty Acid, Esterified,Fatty Acid, Saturated,Saturated Fatty Acids
D005260 Female Females

Related Publications

N Stăncioiu, and M L Scrobohaci, and I Zătreanu, and I Orha
[Relation between platelet aggregation in ischemic heart disease patients and the type of hyperlipoproteinemia].
January 1986, Klinicheskaia meditsina,
N Stăncioiu, and M L Scrobohaci, and I Zătreanu, and I Orha
[Hyperlipoproteinemia and ischemic heart disease].
December 1987, Vnitrni lekarstvi,
N Stăncioiu, and M L Scrobohaci, and I Zătreanu, and I Orha
[Ischemic heart disease and hyperlipoproteinemia].
October 1973, Casopis lekaru ceskych,
N Stăncioiu, and M L Scrobohaci, and I Zătreanu, and I Orha
[Incidence of ischemic heart disease in type V primary hyperlipoproteinemia].
October 1979, Vnitrni lekarstvi,
N Stăncioiu, and M L Scrobohaci, and I Zătreanu, and I Orha
[Relationship between the activity of lecithin cholesterol acyltransferase, hyperlipoproteinemia type and the indicators of the system of hemostasis in chronic ischemic heart disease].
December 1978, Vrachebnoe delo,
N Stăncioiu, and M L Scrobohaci, and I Zătreanu, and I Orha
[Indices of the blood coagulation system in patients with chronic ischemic heart disease in hyperlipoproteinemia].
August 1977, Vrachebnoe delo,
N Stăncioiu, and M L Scrobohaci, and I Zătreanu, and I Orha
[Evaluation of platelet function and tissue plasminogen activator activity in ischemic heart disease depending on concurrence with hyperlipoproteinemia and aspirin therapy].
December 1997, Polskie Archiwum Medycyny Wewnetrznej,
N Stăncioiu, and M L Scrobohaci, and I Zătreanu, and I Orha
[Hyperlipoproteinemia, risk indicators and ischemic heart disease].
April 1989, Vnitrni lekarstvi,
N Stăncioiu, and M L Scrobohaci, and I Zătreanu, and I Orha
[Oral contraceptives, hyperlipoproteinemia and ischemic heart disease].
January 1978, Terapevticheskii arkhiv,
N Stăncioiu, and M L Scrobohaci, and I Zătreanu, and I Orha
[Surgical correction of hyperlipoproteinemia in patients with ischemic heart disease].
February 1984, Kardiologiia,
Copied contents to your clipboard!